Avian retroviruses that have transduced c-myc are useful tools to study the conditions necessary for cellular transformation. FH3, one such retrovirus which encodes a Gag-Myc fusion protein, is not transforming in quail embryonic ®broblasts, but a late variant of FH3 that arose after passaging FH3-infected cells is transforming. Mutational analysis of FH3 revealed that the presence of a portion of the retroviral protease in FH3 inhibited transformation and that this inhibition was transferable to a more highly transforming retrovirus, MC29. Transforming and non-transforming FH3-derived and MC29-derived Gag-Myc proteins were used to further explore characteristics of Myc necessary for transformation. Gag-Myc proteins which were transforming were found to be the most stable in the cell. To distinguish whether transactivation and/or repression is correlated to transformation, the various Gag-Myc fusion proteins were tested for their ability to activate or repress c-Myc targets. Results indicated that a correlation exists between transforming Gag-Myc proteins and their ability to repress, whereas all Gag-Myc proteins could transactivate, regardless of their ability to transform. Taken together, these results suggest that protein stabilization of Myc and repression of target genes by Myc are important for cellular transformation.
Introduction
Myc was ®rst identi®ed as a proto-oncogene that had been transduced by an avian retrovirus (Mladenov et al., 1967) . To date, a number of myc-transducing avian retroviruses have been isolated and characterized including MC29, CMII, OK10, MH2, and FH3 (Lee and Reddy, 1999) . Transduction of cellular myc (cmyc) usually displaces one or more of the viral genes, gag, pol, and env, and renders the resulting virus defective. The Myc protein is expressed as either a polyprotein with viral sequences, or from a spliced mRNA. Such retroviruses can cause myelocytomatosis (from which the name myc is derived), sarcomas, endotheliomas, and carcinomas in birds and can acutely transform both avian ®broblasts and myeloid cells in tissue culture. The avian system is particularly useful because it allows myc transformation to be studied as a one-hit event in primary cells, whereas in mammalian primary cells a second cooperating oncogene such as ras (Land et al., 1983) or pim-1 (Selten et al., 1985) is needed for transformation.
Studies in both avian and mammalian systems have shown that v-Myc proteins are more transforming than c-Myc due to several factors. Mutations in Myc itself contribute highly to the transformation potential of vMyc (Alitalo et al., 1983; Hay¯ick et al., 1985; Reddy et al., 1983; Walther et al., 1986; Watson et al., 1983) . v-Myc encoded by MC29, the most well-studied of the myc-transducing viruses, has 5 ± 7 amino acid substitutions relative to c-Myc, but in particular, a threonine to methionine change at residue 61 renders it more transforming than c-Myc (Frykberg et al., 1987) . Similarly, OK10 and MH2 also contain a key mutation at residue 61 (Hay¯ick et al., 1985; Walther et al., 1986) . Along with genetic rearrangements, overexpression of v-Myc RNA and protein from viral promoters also leads to disruption of c-Myc and v-Myc regulation (Hayward et al., 1981; Linial and Groudine, 1985) .
In addition to protein overexpression, v-Myc proteins and Myc proteins isolated from cancer cell lines and cancer patient samples have been shown to exhibit longer half-lives than their normal cellular counterparts which may contribute to a sustained eect on Myc gene targets (Gavine et al., 1999; Salghetti et al., 1999) . v-Myc was shown to be three times more stable than c-Myc, but with a 61Met-4Thr backmutation, v-Myc was degraded in the same time frame as c-Myc with a half life of 20 ± 30 min (Gavine et al., 1999; Hann and Eisenman, 1984) . v-Mycs from MH2 and T17, a feline myc-transducing retrovirus, were also more stable than c-Myc (Gavine et al., 1999) . Other studies have shown that Myc proteins isolated from lymphoma, glioma, and neuroblastoma cell lines and from lymphoma patient samples have longer half lives than c-Myc, in some cases as much as 110 min (Cohn et al., 1990; Salghetti et al., 1999; Shindo et al., 1993) .
Normal Myc is known be involved in processes including cell cycle progression, inhibition of terminal dierentiation, and apoptosis. Functional assays and structural analysis of Myc indicate that its mode of action is through regulation of gene expression in the nucleus (Henriksson and Luscher, 1996) . The aminoterminal third of Myc is involved in transactivation (Kato et al., 1990; Min and Taparowsky, 1992) , repression (Lee et al., 1996; Li et al., 1994; Penn et al., 1990b) , and transformation (Min and Taparowsky, 1992) while the carboxyl-terminal third contains two nuclear localization signals (Dang and Lee, 1988; Henriksson and Luscher, 1996) , a basic region for sequence-speci®c DNA binding (Blackwell et al., 1993) , and a helix ± loop ± helix leucine-zipper motif that mediates binding to dimerization partners (Crouch et al., 1990) .
FH3 is a myc-containing retrovirus in which v-Myc is very similar to c-Myc. FH3 (also referred to as FE) was isolated from a cranial tumor arising from a 10-day-old chick embryo injected with subgroup A avian leukosis virus (Chen et al., 1989) . It was shown to cause almost exclusively head tumors of macrophage origin in chickens. In tissue culture, FE transforms chicken macrophages but not chicken or quail embryo ®broblasts (QEFs) (Chen et al., 1989; Linial, 1992, 1993) , thus it has narrower host range than other myc-transducing retroviruses, all of which transform ®broblasts (Chen et al., 1989; Frykberg et al., 1987; Walther et al., 1985) . FH3 has only one amino acid substitution that changes a proline to histidine at residue 223 (Tikhonenko and Linial, 1992) . Residue 223 is in the middle third of Myc and outside the regions shown to be required for transformation, transactivation, repression, nuclear localization, DNA binding, and dimerization. MC29 v-Myc, on the other hand, has ®ve or seven amino acid changes, depending on the isolate, distributed between the amino-and carboxyl-terminal thirds of Myc ( Figure 1c ) (Alitalo et al., 1983; Watson et al., 1983) .
Of the well-characterized myc-transducing viruses, FE is unique due to its inclusion of most of the Gag polyprotein, except for the last 43 amino acids of protease, in the Gag-Myc polyprotein (Figure 1b ) (Chen et al., 1989) . Although this 145 kD Gag-Myc fusion protein does not transform QEFs (Chen et al., 1989; Tikhonenko and Linial, 1992) , upon passage of virus in QEFs, variants of FE spontaneously arise within 13 ± 21 passages which are transforming (Tikhonenko and Linial, 1993) . In these ®broblast-transforming variants, such as LE, an internal deletion in the Gag portion of the 145 kD Gag-Myc fusion protein results in a smaller Gag-Myc protein ( Figure  1b) . Direct repeats that¯ank the deletion may have been used during reverse transcription to give rise to the deletion in LE (Tikhonenko and Linial, 1993) . Sequence analysis shows that the deleted region spans the carboxy-terminus of capsid (CA), nucleocapsid (NC), and the amino-terminus of protease (PR) (Figure 1b ). In the virus, CA forms the structural shell, NC binds viral genomic RNA, and PR cleaves Gag and polymerase polyproteins into their constitutive domains (Con, 1996) . In FE, the fusion of Gag and Myc has deleted the carboxy-terminal 43 amino acids of PR (terminal third), so LE only contains the middle third of PR. Since replacement of proline at residue 223 in myc does not change FE and LE with respect to their ability to transformation QEFs (Tikhonenko and Linial, 1992) , the dierences seen in transformation can be attributed to the dierences in Gag alone.
We were interested in determining which portion(s) of the FH3 Gag-Myc fusion protein are important for modulation of Myc transformation. To this end, a series of deletions in Gag were created and tested in transformation assays. Our results show that a region of the PR domain of Gag is responsible for most of the FH3 phenotype. This region of PR can also decrease transformation of MC29 when inserted in frame into the Gag-Myc polyprotein. PR may cause destabilization of the Gag-Myc fusion proteins. Viruses which contain this portion of PR are debilitated in their ability to repress, but not to transactivate, expression of Myc-regulated genes. 
Results

Regions of Gag that inhibit transformation
In previous studies, it was shown that FE is not transforming in QEFs whereas LE is (Tikhonenko and Linial, 1992) . Since both of these viruses contained the same Myc proteins, we wanted to determine the domain(s) of Gag that abrogate ®broblast transformation. LE lacks the carboxyl terminus of CA, all of NC, and the amino half of PR relative to FE (Figure 1b) . Initially our studies on FH3 variants focused on NC as the region that inhibited transformation by FE, because NC has been shown to have DNA-and RNA-binding activities (Campbell and Vogt, 1995; Fu et al., 1988; Gelfand et al., 1993) . NC is critical for viral genomic RNA recognition for packaging (Dupraz and Spahr, 1992) and for virion assembly (Campbell and Vogt, 1995) and has been shown to bind single-and double-stranded RNA and DNA (Gelfand et al., 1993; Karpel et al., 1987) which may be important for processes in the viral life cycle such as reverse transcription (Dib-Hajj et al., 1993) . We had hypothesized that the DNA-binding speci®city of Myc had been altered when expressed as a Gag-Myc fusion protein in the presence of NC. However, in QEF transformation assays, deletion of only NC (FE-NC, Figure 2 ) did not result in as high a level of transformation as did LE (Table 1) . FE results in less than 10 focusforming units (FFU) per milliliter of viral supernatant and FE-NC only conferred 40 FFU/ml while LE gave 410 2 FFU/ml. This ruled out NC as the key domain of Gag that interferes with transformation. Since most of CA was intact in LE and since MC29 contains more of CA than LE and yet is more transforming, we also ruled out the carboxyl terminus of CA as the inhibitory domain. Instead, we focused on PR and created FE-PR ( Figure 2 ). We found that, indeed, PR is the domain which inhibits transformation, since the level of transformation by FE-PR matched that of LE at 410 2 FFU/ml (Table 1) . We also determined whether PR could inhibit transformation by MC29 Gag-Myc. PR was inserted in frame (MC29+PR, Figure 2 ) and virus was assayed for focus formation. As a control, we also introduced the portion of CA and NC deleted in LE into MC29 (MC29+CANC, Figure 2 ). We found that MC29 was more than 200-fold more transforming than MC29+PR (Table 1) . MC29+CANC, on the other hand, only had a decrease in transformation of 10-fold. Although the 5 ± 7 mutations in vMyc of MC29 make it 350-fold more transforming than FE-derived LE, we show here that altering Gag in the MC29 Gag-Myc fusion can aect its transformation pattern in QEFs. Addition of Gag domains, especially PR, can inhibit transformation of QEFs regardless of the inherent activating mutations in myc.
Protein stability of Gag-Myc proteins
Myc proteins that are isolated from some cancer patients have previously been shown to be more stable than c-Myc (Cohn et al., 1990; Salghetti et al., 1999; Shindo et al., 1993) as are v-Myc proteins with the amino acid 61 Thr-4Met mutation (Gavine et al., 1999) . We performed pulse-chase experiments to determine the half-lives of the Gag-Myc proteins used in this study. We found that the transforming variants, FE-PR and LE (Table 1) , were more stable (half life 47 and 48 min, respectively) than the non-transforming variants, FE and FE-NC (half life 35 and 36 min, respectively) (Figure 3a) . Likewise, the more transforming variants of MC29 (Table 1 ) which do not contain PR had half lives of 4120 min for MC29 and of 72 min for MC29+CANC. In contrast, MC29+PR, the least transforming of the MC29-derived constructs we tested, had a half life at 35 min ( Figure 3b ).
Activation by Gag-Myc Proteins
To test transcriptional activities by the Gag-Myc proteins, we used reporter constructs with promoter elements from two known cellular targets of Myc: ornithine decarboxylase (ODC) to study transactivation (Bello-Fernandez et al., 1993; Pena et al., 1993; Wagner et al., 1993) and gadd45 to study repression (Amundson et al., 1998; Bush et al., 1998; Marhin et al., 1997) . When we tested several Gag-Myc proteins for transactivation of an ODC-luciferase construct, we saw that there was no correlation between the degree of transformation and the amount of transactivation (Figure 4 ). All Gag-Myc constructs tested were able to transactivate ODC. FE, a less transforming protein, was also a weaker transactivator than LE and MC29. However, surprisingly, FE-NC which is less transforming than LE and MC29 (Table 1) , was a slightly better transactivator than LE and MC29. P-values 50.05 for FE-NC and MC29 and 40.05 for FE and LE. These results support previous data which suggest that the ability to transactivate Myc-responsive targets does not distinguish transforming from non-transforming Myc proteins (Brough et al., 1995; Li et al., 1994) .
Repression by Gag-Myc proteins
Some previous studies have linked Myc repression and transformation. For example, it was found that the regions of Myc which were required for co-transformation with ras were also required for repression of c-myc (Penn et al., 1990b) . Extensive deletion analysis of the amino terminus of Myc showed that residues 106 ± 143 are necessary for repression of the adenovirus major late promoter (MLP) and that a mutation at residue 115 simultaneously repressed MLP and potentiated transformation of Rat1a cells better than wild-type Myc (Lee et al., 1996; Lee and Dang, 1997) . We tested the FH3-and MC29-derived Gag-Myc proteins for their ability to repress GADD45-luciferase, a reporter previously shown to be repressed by Myc (Amundson reporter alone (Figure 5a ). Likewise, the strongly transforming Gag-Myc proteins, MC29 and MC29+CANC, repressed ®vefold relative to luciferase reporter alone while the less-transforming MC29+PR fails to repress GADD45-luciferase at all (Figure 5b) . Interestingly, MC29 and MC29+CANC, the most transforming Gag-Myc proteins (Table 1 ) repress 2 ± 3 times better than even FE-PR and LE (Figure 5a,b) , perhaps indicating that degree of transformation can be predicted by amount of repression. P-values 50.05 for all constructs except FE-NC and MC29+PR.
Steady state levels of Gag-Myc proteins
We were interested in determining whether dierences in the steady state levels of Gag-Myc proteins could account for the dierences in target gene repression. We were unable to detect Gag-Myc in transiently transfected cells using either RIPA or Western blotting (data not shown). Instead, we examined Gag-Myc steady state protein levels in cells stably transfected with either FE, FE-PR, MC29, or MC29+PR. We found that in each pair, there were no signi®cant dierences in the steady state level of Gag-Myc ( Figure  6 ). Thus, despite dierences in the half lives of the proteins, it is unlikely that the steady state levels of Gag-Myc can account for the dierences in regulation of transcriptional targets.
Discussion
The results presented here show that the domain in FH3 Gag-Myc that has the greatest suppressive eect on viral transformation is PR. Our initial focus was on Figure 4 Transactivation of ODC-luciferase reporter does not correlate to degree of transforming ability. c-Myc is a positive control for transactivation. Transient transfection assays were done using an ODC-luciferase reporter gene (Luc). Fold dierences between given Gag-Myc proteins were normalized to luciferase reporter alone. All results reported are relative to an internal CMV-bgal construct. The results of three experiments, each in triplicate are shown here. For each experiment, 1 mg ODC-luciferase plasmid, 2.5 mg Gag-Myc expression plasmid and 1 mg CMV-bgal plasmid were used. RLU=relative light units NC because it could have interfered with the DNAbinding speci®city of Myc in the Gag-Myc fusion protein due its inherent ability to bind nucleic acids. As a consequence, transformation may have been abrogated, but our results indicated that NC does not inhibit transformation to a signi®cant extent (Table 1) . Instead, PR attenuated the transforming potential of vMyc proteins that are virtually identical to c-Myc, as in the case of FE, as well as highly mutated and transforming v-Myc proteins such as MC29. The attenuation of transformation is through an unknown mechanism, however, it is highly unlikely that it is due to the proteolytic activity of PR. Avian PR, as other retroviral proteases, only functions as a dimer (Grinde et al., 1992) with subunits oriented and stabilized to each other by interactions between the amino-and carboxyl-terminuses of each subunit (Oertle et al., 1992) . Since all FE-derived Gag-Myc proteins are missing the carboxyl-terminal portion of PR, it is unlikely that correctly oriented, functional dimers can be formed. Also, avian PR has 10-fold lower activity than mammalian PR proteins and is only active at higher concentrations of PR subunits, as is the case inside a virion (Vogt, 1996) . Avian retroviral PR is found in 20-fold higher concentration inside virions than is mammalian retroviral PR because it is encoded as part of the Gag polyprotein rather than a part of the polymerase polyprotein as in mammalian retroviruses. The Gag-Myc proteins that have been studied here would also have to be at very high concentration in order for PR to be active. In addition, all FE-derived Gag-Myc proteins are missing residues 98 ± 111 which are needed for substrate binding (Grinde et al., 1992; Loeb et al., 1989) . However, PR could modulate Myc transformation by altering the conformation of Myc in relation to binding to DNA and/or other proteins. Non-transforming FE and transforming LE Gag-Myc proteins dier in PR by the amino-terminal 38 amino acids while sharing the middle 43 amino acids of PR (Figure 1 ). These 38 amino acid residues present in FE but not LE are predicted to be highly ordered, with most of the residues in b-sheets interrupted by a 10-residue loop (Grinde et al., 1992) . This loop is thought to have a structural role in viral particle assembly (Grinde et al., 1992; Oertle et al., 1992) . Possible protein ± protein interactions mediated by the b-sheets and/or the loop may inhibit binding between Myc and its co-factors and target genes when it is present in FE.
Since we had a panel of related constructs, some of which were transforming and some of which were not, we wanted to characterize them with respect to their ability to regulate gene expression. Early studies showed that the amino terminus of Myc is required for both transformation and transactivation (Henriksson and Luscher, 1996; Kato et al., 1990; Meichle et al., 1992) , which led to the conclusion that transactivation is necessary for transformation, but other evidence S-methionine/cysteine, then lysed for analysis by immunoprecipitation. FE and FE-PR were run on a 6% polyacrylamide gel and MC29 and MC29+PR were run on a 10% polyacrylamide gel Oncogene Transformation by Gag-Myc proteins W Law and ML Linial suggested that repression is also closely linked to transformation (Claassen and Hann, 1999; Lee et al., 1996; Lee and Dang, 1997; Penn et al., 1990b) . We found that the ability to activate a Myc-responsive target does not distinguish transforming from non-transforming Gag-Myc proteins. Since overexpression of ODC alone can cause transformation, it might be expected that ODC activation could be linked to Myc-induced transformation (Auvinen et al., 1992; Moshier et al., 1993) . We did not ®nd that MC29, the most transforming of the Gag-Myc proteins tested here, activated ODC more than the other Gag-Myc proteins (Figure 4) . Myc Box II (MBII) in the amino-terminal domain of c-Myc is required for transformation, but not for transactivation of ODC, suggesting that ODC activation is not the only means by which Myc can transform cells (BelloFernandez et al., 1993) . Interestingly, MBII is also required for Myc association with histone acetylation complexes which are implicated in gene activation, so Myc may be involved on a more global level of gene activation rather than activation of speci®c genes that lead to transformation (McMahon et al., 2000) .
Myc can also act as a repressor of cellular genes that are important for inhibiting cell cycle progression such gadd45 (Amundson et al., 1998; Marhin et al., 1997) . gadd45 arrests the cell cycle after induction by DNA damage and growth arrest conditions such as serum deprivation (Fornace et al., 1988 (Fornace et al., , 1989 Zhan et al., 1994) . Ectopic expression of gadd45 protein strongly blocks proliferation in the human carcinoma cell line HeLa and non-transformed murine cell lines (Vairapandi et al., 1996; Zhan et al., 1994) . In addition, a positive correlation between repression of adenovirus MLP and increase in transformation by c-Myc was demonstrated (Lee et al., 1996; Lee and Dang, 1997) as well as a connection between repression of c-myc and increase in co-transformation with ras (Penn et al., 1990a,b) . Conversely, a Myc mutant with decreased repression and decreased transformation ability was found to have increased transactivation ability (Lee and Dang, 1997) . We have shown that PR not only interferes with transformation, but it also interferes with GADD45-luciferase repression when present in Gag-Myc fusion proteins. As some cellular repression targets for Myc proteins are thought to be involved in cell cycle regulation, transformation could result from disruption of the delicate balance of these regulators. We have found that the ability to repress a Myc-responsive target can be a biochemical criterion by which to distinguish transforming from non-transforming Gag-Myc proteins.
Our data con®rm results of others that increased Myc stability in the cell is related to transforming ability (Gavine et al., 1999; Salghetti et al., 1999) . However, we found that the dierences in Gag-Myc protein half-lives were not re¯ected in the steady state levels ( Figure 6 ). This is consistent with recent analyses of co-transformation in rat embryo ®broblasts and repression in rat myc-null cells reconstituted with wildtype and mutated murine c-Myc proteins (Chang et al., 2000) . In this study, it was found that the steady state levels of various c-Myc proteins mutated in the amino terminus were unchanged despite dierences in transforming potential, although the protein half-lives were not determined.
From our results, we do not know the causal relationship between protein stabilization and repression, and how this may lead to transformation. Protein stabilization may enhance the ability of Myc to promote transformation and tumorigenesis by providing a larger intracellular pool of Myc to chronically drive cells into proliferation. With a longer half life, Gag-Myc proteins can target genes such as gadd45 for repression and keep them turned o in the face of other potential counteracting factors. This presumes that protein stability causes more ecient repression. Alternatively, ability to bind to repression targets in the nucleus may protect transforming Gag-Myc fusion proteins from proteases. In this scenario, repression is the cause of protein stability. Still another possibility is that protein stabilization is a consequence of cellular changes promoted by transformation and not related to repression at all. In any case, protein stability can be a useful tool in distinguishing transforming from nontransforming Gag-Myc proteins biochemically despite the current lack of a known mechanism.
One possible mechanism for the stabilization of Myc is through dimerization partners. This has been shown to be the case for the transcription factor E2F. Rb binds to and stabilizes E2F which can then function as a repressor, but in the absence of Rb, E2F is an unstable activator (Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et al., 1996) . We see a similar pattern in which repression and stabilization coincide in our Gag-Myc proteins. One dimerization partner that putatively links Myc to repression is Miz-1. Miz-1 was recently identi®ed by two-hybrid cloning as a zinc-®nger protein that associates with the carboxyl terminus of Myc . It has been reported to form a heterodimer with Myc that can repress reporter constructs . In addition, Myc dimerization with Miz-1 stabilizes Myc by inhibiting ubiquitin-mediated proteolysis (Salghetti et al., 1999) , and a possible mechanism for Myc stabilization is through modi®cation of the proteolytic machinery. Ras has been reported to stabilize Myc though a mechanism that is proteasome-dependent (Sears et al., 1999) . Even though Myc and Ras do not directly dimerize, they cooperate in transformation which may be mediated through Ras inhibition of Myc degradation. It is also possible that stability alone may not determine transforming ability of any Myc protein. Indeed, one Myc protein from a cancer cell line was found to have a similar half-life to wild-type Myc (Salghetti et al., 1999) , so most probably transformation is a result of a combination of Myc protein stabilization and Myc protein function such the ability to repress target genes. In all, a better understanding of the biochemical and functional dierences between transforming and non-transforming Myc proteins will shed light on the involvement of Myc in normal cellular processes and on the processes of transformation and tumorigenesis.
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Materials and methods
Cloning of constructs
All Gag-Myc constructs were made in an RCASBP background (Petropoulos and Hughes, 1991) . The construction of RCAS/FE, RCAS/MC29, and RCAS/LE was previously described (Tikhonenko and Linial, 1992) . FE is wild-type FH3 Gag-Myc while LE is FH3 Gag-Myc containing a spontaneous deletion which leads to ®broblast transformation. Brie¯y, PCR products spanning gag and myc were cloned into RCAS/BP replacing gag and pol. The Myc portion of the Gag-Myc proteins encoded by FE and LE is identical. RCAS/FE-NC and RCAS/FE-PR were both derived from RCAS/FE. PCR primers were made to create a unique restriction site for BstBI in place of the deleted domain. Templates and primers are shown in Figure 2 . These PCR products were ligated into pBS/FE/Xho-Xho [XhoI (in gag) to XhoI (downstream of myc) in pBluescript SK + (Stratagene)], a subclone of RCAS/FE, using BglII and SacI sites to join inserts to plasmid and BstBI site to seal the engineered unique restriction site. From these subclones a BglII ± NotI fragment was cloned back into RCAS/FE to give the desired deletion in a viral context. RCAS/MC29+PR and RCAS/MC29+CANC were both derived from RCAS/MC29. To create RCAS/MC29+PR, a PCR product containing protease was inserted into the gagmyc junction of RCAS/MC29. Templates and primers are shown in Figure 2 . PCR products 1, 2, and 3 for RCAS/ MC29+PR ( Figure 2 ) were used as templates in the next round of PCR to generate a ®nal cloning insert. To create RCAS/MC29+CANC, a PCR product containing the carboxyl terminus of capsid and all of nucleocapsid was inserted into the gag-myc junction of RCAS/MC29. PCR products 1 and 2 for RCAS/MC29+CANC (Figure 2 ) were used as templates in the next round of PCR to generate a ®nal cloning insert. These ®nal inserts were cloned directly into RCAS/MC29 using BglII and NotI sites.
Cell culture
Experiments were performed using secondary quail embryonic ®broblasts (QEFs) cultured in GM+D+CK complete growth medium (Ham's F-10 media, 10% tryptose phosphate broth, 5% bovine calf serum (Hyclone), 333 mM sodium bicarbonate, 1% 10 000 U/ml Nystatin (Gibco ± BRL), 1% dimethyl sulfoxide, 1% heat-inactivated chicken serum (Gibco ± BRL)) in a 378C incubator with 6% CO 2 . For replication-competent viral stocks, QEFs were co-transfected as previously described (Chen and Okayama, 1996) with RCASBP neo, a replication-competent RSV-derived vector containing the neomycin selectable marker in place of src, and the appropriate Gag-Myc construct in a 10 : 1 ratio. Cells were split 1 : 5 at 48 h after transfection and selected for resistance against G418 over 7 days. After selection, fresh media was added to pools of resistant cells and supernatants containing virus were harvested after 18 h. Viral titers were normalized using RT ± PCR to myc RNA levels using primers in v-myc. Focus formation assays were done using QEFs as previously described (Linial, 1982; Tikhonenko and Linial, 1992) . Foci were counted 14 days after initial infection. For luciferase assays, QEFs were transiently transfected as previously described (Chen and Okayama, 1996) .
Protein analysis
Prior to radiolabeling, cells for pulse-chase analysis were incubated for 30 min in Dulbecco's Modi®ed Eagle's Medium (DMEM) lacking L-methionine and L-cysteine (Sigma)+10% dialyzed fetal bovine serum (Gibco ± BRL). Cells were then labeled with L-35 S-methionine and L-35 S-cysteine (NEN) in Met(7)Cys(7) DMEM for 10 min, washed twice with GM+D+CK medium, incubated in GM+D+CK for the time periods given, then analysed by immunoprecipitation (IP). For looking at steady state levels of protein, cells were labeled for 1 h with L-35 S-methionine and L-35 S-cysteine in Met(7)Cys(7) DMEM, then immediately lysed for IP. Immunoprecipitation was carried out as previously described using polyclonal 4638 rabbit serum generated against an antiMyc epitope (Luscher et al., 1989) . Proteins were run on 6 ± 10% SDS ± PAGE gels and visualized by phosphorimaging (Molecular Dynamics).
Luciferase assays
Reporter constructs used were ODC-luciferase (gift from the RN Eisenman Lab), made by introducing a HindIII ± HindIII fragment containing the regulatory regions from Kpn-ODCCAT (chloramphenicol acetyltransferase) plasmid (Mao et al., 1993) into pGL2 basic plasmid (Promega), and GADD45-luciferase (Amundson et al., 1998; Zhan et al., 1998) . RCAN/c-myc was used as a control expression plasmid (Crouch et al., 1990) . Extracts from QEFs were prepared 72 h post-transfection. Luciferase assays were performed as previously described (Brasier and Fortin, 1995) . b-galactosidase assays were performed with these same cell lysates diluted 1 : 100 in Triton/glycylglycine lysis buer as previously described (Biegalke and Geballe, 1990) .
